Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001–2016
نویسندگان
چکیده
Millions of people, particularly in low- and middle-income countries, lack access to effective pharmaceuticals, often because they are unaffordable. The 2001 Ministerial Conference of the World Trade Organization (WTO) adopted the Doha Declaration on the TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement and Public Health. The declaration recognized the implications of intellectual property rights for both new medicine development and the price of medicines. The declaration outlined measures, known as TRIPS flexibilities, that WTO Members can take to ensure access to medicines for all. These measures include compulsory licensing of medicines patents and the least-developed countries pharmaceutical transition measure. The aim of this study was to document the use of TRIPS flexibilities to access lower-priced generic medicines between 2001 and 2016. Overall, 176 instances of the possible use of TRIPS flexibilities by 89 countries were identified: 100 (56.8%) involved compulsory licences or public noncommercial use licences and 40 (22.7%) involved the least-developed countries pharmaceutical transition measure. The remainder were: 1 case of parallel importation; 3 research exceptions; and 32 non-patent-related measures. Of the 176 instances, 152 (86.4%) were implemented. They covered products for treating 14 different diseases. However, 137 (77.8%) concerned medicines for human immunodeficiency virus infection and acquired immune deficiency syndrome or related diseases. The use of TRIPS flexibilities was found to be more frequent than is commonly assumed. Given the problems faced by countries today in procuring high-priced, patented medicines, the practical, legal pathway provided by TRIPS flexibilities for accessing lower-cost generic equivalents is increasingly important.
منابع مشابه
TRIPs-Plus Treaties and Strengthening Protection of Pharmaceutical Inventions
After concluding TRIPs agreement, the sphere of negotiation in respect of protecting new kinds of intellectual property rights especially pharmaceutical inventions transferred to bilateral and regional arrangements. TRIPs agreement has some flexibility to attract all countries. Industrialized countries believed that multilateral agreements protections based especially in regard of pharmaceutica...
متن کاملThe examination of intellectual right of medicinal plants and the issue of bio-theft due to agreement of TRIPS
Over the past two decades, the role of intellectual property rights in all areas of science and technology has exploded globally– primarily due to the rules prescribed by the World Trade Organization’s TRIPS and by bilateral/regional trade agreements. The TRIPS agreement obligates all WTO member countries to adopt and enforce minimum standards of intellectual property rights. The TRIPS agreemen...
متن کاملThe examination of intellectual right of medicinal plants and the issue of bio-theft due to agreement of TRIPS
Over the past two decades, the role of intellectual property rights in all areas of science and technology has exploded globally– primarily due to the rules prescribed by the World Trade Organization’s TRIPS and by bilateral/regional trade agreements. The TRIPS agreement obligates all WTO member countries to adopt and enforce minimum standards of intellectual property rights. The TRIPS agreemen...
متن کاملFlexibilities provided by the Agreement on Trade-Related Aspects of Intellectual Property Rights
متن کامل
حمایت قانونی از ابداعات دارویی در پرتو مطالعهی تطبیقی
Among the challenging issues of intellectual property law, discussed how to support and protect the drug because of its association with health in developing countries of particular importance and significance of the day incidence has been added. Pharmaceutical products, sometimes due to a combination of two or more chemical or combination of two or more existing drugs to create new drug is som...
متن کامل